Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy (Q39138583)

From Wikidata

Revision as of 16:57, 21 November 2022 by Cewbot (talk | contribs) (‎Removed claim: author name string (P2093): Hasuo K, Modify PubMed ID: 1779238 citation data from NCBI, Europe PMC and CrossRef)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on November 1, 1991

Language	Label	Description	Also known as
English	Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy	scientific article published on November 1, 1991

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy (English)

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Human T-lymphotropic virus 1

0 references

magnetic resonance imaging

0 references

1 reference

based on heuristic

inferred from title

spastic paraparesis

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

author name string

J. Kira

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779238

21 November 2022

K. Fujihara

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779238

21 November 2022

Y. Itoyama

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779238

21 November 2022

I. Goto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779238

21 November 2022

K. Hasuo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779238

21 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1779238

21 November 2022

publication date

1 November 1991

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:0022510X9190192A?httpAccept=text/xml

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

https://api.elsevier.com/content/article/PII:0022510X9190192A?httpAccept=text/plain

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Journal of the Neurological Sciences

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

41-49

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.

1

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Topological characteristics of brainstem lesions in clinically definite and clinically probable cases of multiple sclerosis: an MRI-study

2

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

3

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy.

4

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP).

5

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Human T-lymphotropic virus type I-associated myelopathy presenting as spinocerebellar syndrome

6

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Immunological studies in tropical spastic paraparesis

7

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Shy-Drager syndrome and human T-lymphotropic virus type I infection

8

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

9

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis.

10

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Leukoencephalopathy in HTLV-I-associated myelopathy: MRI and EEG data

11

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

A new scale for evaluating disability in multiple sclerosis

12

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Nuclear magnetic resonance imaging in multiple sclerosis.

13

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Central-nervous-system lesions detected by magnetic resonance imaging in an HTLV-1 antibody positive symptomless individual

14

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis

15

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells

16

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Identity of HTLV-I-associated tropical spastic paraparesis and HTLV-I-associated myelopathy.

17

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients

19

1 reference

10.1016/0022-510X(91)90192-A

https://api.crossref.org/works/10.1016/0022-510X(91)90192-A

21 November 2022

Identifiers

10.1016/0022-510X(91)90192-A

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39138583&oldid=1776531797"